A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy
These findings highlight dIT's potential role in primary prophylaxis against MBM, with anti-PD1 as the likely workhorse agent. Prospective studies are warranted.
Authors
- Jeffrey Sivik (ORCID: https://orcid.org/0000-0002-3259-1584)
- Ahmad Ozair (ORCID: https://orcid.org/0000-0001-6570-4541)
- Joseph J. Drabick (ORCID: https://orcid.org/0000-0002-7630-2721)
- Manmeet S. Ahluwalia (ORCID: https://orcid.org/0000-0003-3794-9511)
- Alireza Mansouri (ORCID: https://orcid.org/0000-0002-7442-7539)
- Junjia Zhu (ORCID: https://orcid.org/0000-0003-1311-3752)
- Hannah Wilding (ORCID: https://orcid.org/0000-0001-8771-2390)
- Colette R. Pameijer (ORCID: https://orcid.org/0000-0002-1967-0501)
- Jorge Benavides‐Vasquez (ORCID: https://orcid.org/0000-0002-7834-1150)
- Leonardo de Macêdo Filho (ORCID: https://orcid.org/0000-0002-8146-7889)
- Aarav Badani (ORCID: https://orcid.org/0000-0002-4469-138X)
- Debarati Bhanja (ORCID: https://orcid.org/0000-0002-0591-5547)
- Camille Moeckel (ORCID: https://orcid.org/0009-0001-9808-4841)
- Kim Margolin (ORCID: https://orcid.org/0000-0002-5248-4356)
- Jinpyo Hong (ORCID: https://orcid.org/0009-0004-9256-9233)
Institutions
- University of Maryland, Baltimore (US)
- Baptist Hospital of Miami (US)
- Pennsylvania State University (US)
- Johns Hopkins University (US)
- Florida International University (US)
- NYU Langone Health (US)
- Baptist Health South Florida (US)
- Department of Public Health (MM)
- Retina Partners (US)
- New York University (US)
- Penn State Milton S. Hershey Medical Center (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-2681
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Division of Cancer Epidemiology and Genetics, National Cancer Institute